Moreover, Figure S1 demonstrated that in tumor-infiltrated immune cells of colon cancer, breast cancer, gastric cancer, and melanoma, NKG2A and IL-2Rβ were predominantly co-expressed in CD8+ T cells (85–96.6%) and NK cells (1.7–11.5%). This evidence concerns the gene KLRC1 and breast cancer.